AgPlus Diagnostics

AgPlus Diagnostics has developed a diagnostic platform technology based on research conducted at the UK’s National Physical Laboratory (NPL).

AgPlus’ platform technology combines novel electrochemistry and metallic nanoparticles signalling with diagnostic immunoassays to provide high sensitivity and fully quantitative analyte detection. The AgPlus ADVANTAGE handheld portable reader and single-use test cartridge are expected to be used across multiple applications and sectors, critically where fast cost-effective diagnostic results will enable users to make decisions, with confidence, in minutes, not hours or days.

Read our CEO Spotlight interview with AgPlus CEO, Fiona Marshall.

Fiona Headshot



Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

UK Innovation & Science Seed Fund Invests in AgPlus Diagnostics

AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics UK Innovation &…

read more

More Companies in Medical / Biotechnology